Huize Pharmaceutical

Hunan Huize Biomedical Technology Co., Ltd. (abbreviated as "Huize Pharmaceutical") was established in 2014 and is dedicated to becoming a globally outstanding professional service platform for drug research and development and evaluation!
Headquartered at Wanwei Technology Industrial Park, No. 136 Wanglong Road, Changsha High-tech Zone, Huize Pharmaceutical has two subsidiaries: Hunan Taixin Pharmaceutical Technology Co., Ltd., focusing on pharmaceutical research and testing technical services, and Hunan Huiling Digital Technology Co., Ltd., focusing on clinical trial collaborative service platforms for subject-related matching services.
Huize Pharmaceutical has always adhered to the principles of "humility and benevolence, virtue like water" in conduct, "pragmatic innovation, pursuit of excellence" in technology, and "quality and efficiency, customer success" in service. Huize Pharmaceutical has jointly established clinical trial specialties with multiple hospitals including Xiangya Hospital, with a quality system covering all clinical institutions, analytical testing centers, SMO, and data management statistical analysis units, ensuring that the entire service process complies with ICH-GCP standards. In collaboration with Central South University, it has established the Hunan Engineering Research Center for Self-emulsifying Innovative Formulation Technology, the Engineering Technology Research Center for Pharmaceutical Formulation Optimization and Early Clinical Evaluation, the Biopharmaceutics and Pharmacokinetics Research Center, the Topical Formulation Clinical Evaluation Center, and the Pharmacoeconomics Evaluation Center. The Huize research team has innovated antibody drug pharmacokinetic models, local administration drug pharmacokinetic models, and intelligent IVIVC devices. Together with dozens of tertiary hospitals across the country including Xiangya Hospital of Central South University, it has jointly established the National Skin Topical Drug Research Alliance, accumulating rich clinical modeling experience in the fields of long-acting injectables and skin topical drugs.
Huize Pharmaceutical has established long-term, friendly strategic partnerships with more than 200 pharmaceutical companies and pharmaceutical research institutions both domestically and internationally, completing over 700 technical service projects including Phase I-II clinical trials for innovative drugs and PK/BE trials for generic drugs. Huize Pharmaceutical always adheres to the "customer-centric" technical service philosophy of being not just a service provider but a problem solver, utilizing innovative theories of in vivo absorption and dissolution kinetics of pharmaceutical formulations, in vitro bridging technologies, models, and devices to provide customers with efficient, high-quality, highly interactive, full-process professional services from pharmaceutical research to clinical evaluation in drug development, helping pharmaceutical companies reduce R&D risks, shorten R&D cycles, save R&D costs, and improve R&D success rates.
Continuously creating value for customers is the reason for Huize Pharmaceutical's existence. We will, as always, insist on providing free formulation optimization and clinical trial protocol optimization consulting services, meeting unmet clinical needs, and helping pharmaceutical companies upgrade their products and brands.